Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe page now displays 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label (Intervention/Treatment added vs Intervention / Treatment removed) and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check10 days agoChange DetectedVersion label on the page changed from v3.5.4 to v3.5.5, indicating a new page release. The study content remains unchanged.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, representing a minor update to the page metadata. There is no indication of changes to the study details or results.SummaryDifference0.0%

- Check38 days agoChange DetectedTaiwan location entry updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the study's locations list while keeping the same postal code, ensuring accurate site identification for potential participants.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study record.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.